Figure 1. Frequency of hyperlactatemia* in infants born to HIV-infected mothers and exposed to antiretovirals during pregnancy. ANRS 1269 study, Abidjan, Côte d’Ivoire (2002–2005).
sdNVP: single-dose of nevirapine
ZDV+sdNVP: zidovudine (ZDV) from 36 weeks of gestation and single-dose of nevirapine
ZDV+3TC+sdNVP: zidovudine (ZDV) + lamivudine (3TC) from 32 weeks of gestation and single-dose of nevirapine
*>=2.5 mmol/L on two consecutives measurements in a series of three